Portal de Periódicos da CAPES

Laboratory processing of cerebrospinal fluid specimens

1990; Wiley; Volume: 6; Issue: 2 Linguagem: Inglês

10.1002/dc.2840060215

8755-1039

J. M. Andrews, Günter Schumann,

Pleural and Pulmonary Diseases

Diagnostic CytopathologyVolume 6, Issue 2 p. 139-143 Consultation Corner Laboratory processing of cerebrospinal fluid specimens John M. Andrews M.D., John M. Andrews M.D. Department of Pathology, Division of Cytology, School of Medicine, University of Utah, Salt Lake City, UT.Search for more papers by this authorG. Berry Schumann M.D., Corresponding Author G. Berry Schumann M.D. Department of Pathology, Division of Cytology, School of Medicine, University of Utah, Salt Lake City, UT.Director, Cytopathology and Cytotechnology, Department of Pathology, Division of Cytology, School of Medicine, University of Utah, Salt Lake City, UT 84132Search for more papers by this author John M. Andrews M.D., John M. Andrews M.D. Department of Pathology, Division of Cytology, School of Medicine, University of Utah, Salt Lake City, UT.Search for more papers by this authorG. Berry Schumann M.D., Corresponding Author G. Berry Schumann M.D. Department of Pathology, Division of Cytology, School of Medicine, University of Utah, Salt Lake City, UT.Director, Cytopathology and Cytotechnology, Department of Pathology, Division of Cytology, School of Medicine, University of Utah, Salt Lake City, UT 84132Search for more papers by this author First published: March 1990 https://doi.org/10.1002/dc.2840060215Citations: 4AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Albright RE Jr, Christenson RH, Habig RL, et al. Cerebrospinal fluid (CSF) trap. A method to improve CSF laboratory efficiency. Am J Clin Pathol 1988; 90: 707– 10. 2 Hooshmand H, Escobar MR, Kopf SW. Neurosyphilis. A study of 241 patients. JAMA 1972; 219: 726– 9. 3 Fishman RA. Cerebrospinal fluid in diseases of the nervous system. Philadelphia: Saunders, 1980. 4 Kjeldsberg CR, Krieg AF. Cerebrospinal fluid and other body fluids. In: JB Henry, ed. Clinical diagnosis and management by laboratory methods. 17th ed. Philadelphia: Saunders, 1984: 459– 75. 5 Cheson BD. Clinical utility of body fluid analysis. Clin Lab Med 1985; 5: 195– 208. 6 Kjeldsberg CR, Knight JA. Body fluids. 2nd ed. Chicago: ASCP Press, 1986: 31– 73. 7 Schumann GB, Crisman LG. Cerebrospinal fluid cytopathology. Clin Lab Med 1985; 5: 275– 302. 8 Schumann GB, Crisman LG. Semiquantitative approach to CSF cytopathology. Diagn Cytopathol 1986; 2: 194– 7. 9 Koss LG. Diagnostic cytology and its histopathologic bases. 3rd ed. Philadelphia: Lippincott, 1979: 1183. 10 Shenoy UA, Kushner JP, Schumann GB. Cytologic diagnosis and monitoring of Hodgkin's disease in cerebrospinal fluid: a case report. Diagn Cytopathol 1987; 3: 323– 5. 11 Coleman A, Schumann GB. Cytodiagnosis and monitoring of acute lymphocytic leukemia and eosinophilia in cerebrospinal fluid. Diagn Cytopathol 1987; 3: 330– 4. 12 Kun LE, D'Souza B, Tefft M. The value of surveillance testing in childhood brain tumors. Cancer 1985; 56: 1818– 23. 13 Rautonen J, Koskiniemi M, Siimes MA, et al. Elevated cerebrospinal fluid fibronectin concentration at diagnosis indicates poor prognosis in children with acute lymphoblastic leukemia. Int J Cancer 1989; 43: 32– 5. 14 Graus F, Segurado OG, Tolosa E. Selective concentration of anti-Purkinje cell antibody in the CSF of two patients with paraneoplastic cerebellar degeneration. Acta Neurol Scand 1988; 78: 210– 3. 15 Heideman RL, Cole DE, Balis F, et al. Phase I and pharmacokinetic evaluation of thiotepa in the cerebrospinal fluid and plasma of pediatric patients: evidence for dose-dependent plasma clearance of thiotepa. Cancer Res 1989; 49: 736– 41. 16 Schwartsmann G, VanDer Vijgh WJF, Klein I, et al. Pharmacokinetics of brequinar sodium (NSC 368390; DUP 785) in cerebrospinal fluid. Eur J Cancer Clin Oncol 1988; 24: 1903– 4. 17 Boogerd W, Vroom ThM, VanHeerde P, et al. CSF cytology versus immunocytochemistry in meningeal carcinomatosis. J Neurol Neuro-surg Psychiatr 1988; 51: 142– 5. 18 Hancock WW, Medley G. Monoclonal antibodies to identify tumour cells in CSF. Lancet 1983; 2: 739– 40. 19 Coakham HB, Brownell B, Harper EI, et al. Use of monoclonal antibody panel to identify malignant cells in cerebrospinal fluid. Lancet 1984; 1: 1095– 8. 20 Jaeckle KA. Assessment of tumor markers in cerebrospinal fluid. Clin Lab Med 1985; 5: 303– 15. 21 Koskiniemi M. Malignancy markers in the cerebrospinal fluid. Eur J Pediatr 1988; 148: 3– 8. 22 Wittwer C, Director of Flow Cytometry, Department of Pathology, University of Utah. Personal communication, 1989. 23 Cibas ES, Malken MG, Posner JB, et al. Detection of DNA abnormalities by flow cytometry in cells from cerebrospinal fluid. Am J Clin Pathol 1987; 88: 570– 7. 24 Chofflon M, Weiner HL, Morimoto C, et al. Decrease of supressor inducer (CD4+, 2H4+) T cells in multiple sclerosis cerebrospinal fluid. Ann Neurol 1989; 25: 484– 99. 25 Salonen R, Ilonen J, Jagerroos H, et al. Lymphocyte subsets in the cerebrospinal fluid in active multiple sclerosis. Ann Neurol 1989; 25: 500– 2. 26 Saiki RK, Scharf S, Faloona F, et al. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 230: 1350– 4. 27 Shibata D, Martin WJ, Arnheim N. Analysis of DNA sequences in forty-year-old paraffin-embedded thin-tissue sections: a bridge between molecular biology and classical histology. Cancer Res 1988; 48: 4564– 6. 28 Stetler-Stevenson M, Raffeld M, Cohen P, et al. Detection of occult follicular lymphoma by specific DNA amplification. Blood 1988; 72: 1822– 5. 29 Kawasaki ES, Clark SS, Coyne MY, et al. Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci USA 1988; 85: 5698– 702. Citing Literature Volume6, Issue2March 1990Pages 139-143 ReferencesRelatedInformation